222 related articles for article (PubMed ID: 20438795)
1. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats.
Tonomura Y; Tsuchiya N; Torii M; Uehara T
Toxicology; 2010 Jun; 273(1-3):53-9. PubMed ID: 20438795
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.
Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K
J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298
[TBL] [Abstract][Full Text] [Related]
3. Renal biomarkers predict nephrotoxicity after paraquat.
Wunnapuk K; Liu X; Peake P; Gobe G; Endre Z; Grice JE; Roberts MS; Buckley NA
Toxicol Lett; 2013 Oct; 222(3):280-8. PubMed ID: 23954200
[TBL] [Abstract][Full Text] [Related]
4. Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney injury.
Sinha V; Vence LM; Salahudeen AK
J Investig Med; 2013 Mar; 61(3):564-8. PubMed ID: 23360846
[TBL] [Abstract][Full Text] [Related]
5. Rat Urinary Osteopontin and Neutrophil Gelatinase-Associated Lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury.
Phillips JA; Holder DJ; Ennulat D; Gautier JC; Sauer JM; Yang Y; McDuffie E; Sonee M; Gu YZ; Troth SP; Lynch K; Hamlin D; Peters DG; Brees D; Walker EG
Toxicol Sci; 2016 Jun; 151(2):214-23. PubMed ID: 27026710
[TBL] [Abstract][Full Text] [Related]
6. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
Hosohata K; Ando H; Fujimura A
J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
[TBL] [Abstract][Full Text] [Related]
7. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
[TBL] [Abstract][Full Text] [Related]
8. Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats.
Quesada A; Vargas F; Montoro-Molina S; O'Valle F; Rodríguez-Martínez MD; Osuna A; Prieto I; Ramírez M; Wangensteen R
PLoS One; 2012; 7(7):e40402. PubMed ID: 22792302
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria increases cystatin C excretion: implications for urinary biomarkers.
Nejat M; Hill JV; Pickering JW; Edelstein CL; Devarajan P; Endre ZH
Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii96-103. PubMed ID: 21551085
[TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels.
Lin HY; Lee SC; Lin SF; Hsiao HH; Liu YC; Yang WC; Hwang DY; Hung CC; Chen HC; Guh JY
Kaohsiung J Med Sci; 2013 Jun; 29(6):304-11. PubMed ID: 23684135
[TBL] [Abstract][Full Text] [Related]
11. Urinary cystatin C and NGAL as early biomarkers for assessment of renal ischemia-reperfusion injury: a serum marker to replace creatinine?
Woodson BW; Wang L; Mandava S; Lee BR
J Endourol; 2013 Dec; 27(12):1510-5. PubMed ID: 24266750
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the usefulness of novel biomarkers for drug-induced acute kidney injury in beagle dogs.
Zhou X; Ma B; Lin Z; Qu Z; Huo Y; Wang J; Li B
Toxicol Appl Pharmacol; 2014 Oct; 280(1):30-5. PubMed ID: 25034533
[TBL] [Abstract][Full Text] [Related]
13. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
[TBL] [Abstract][Full Text] [Related]
14. Tubular Injury Biomarkers to Detect Gentamicin-Induced Acute Kidney Injury in the Neonatal Intensive Care Unit.
Jansen D; Peters E; Heemskerk S; Koster-Kamphuis L; Bouw MP; Roelofs HM; van Oeveren W; van Heijst AF; Pickkers P
Am J Perinatol; 2016 Jan; 33(2):180-7. PubMed ID: 26344007
[TBL] [Abstract][Full Text] [Related]
15. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
16. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity.
Prozialeck WC; Edwards JR; Vaidya VS; Bonventre JV
Toxicol Appl Pharmacol; 2009 Aug; 238(3):301-5. PubMed ID: 19371616
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury.
Sasaki D; Yamada A; Umeno H; Kurihara H; Nakatsuji S; Fujihira S; Tsubota K; Ono M; Moriguchi A; Watanabe K; Seki J
Biomarkers; 2011 Nov; 16(7):553-66. PubMed ID: 21955166
[TBL] [Abstract][Full Text] [Related]
19. Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.
Pais GM; Avedissian SN; O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Lamar PC; Cluff C; Gulati A; Fitzgerald JC; Downes KJ; Zuppa AF; Scheetz MH
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988153
[TBL] [Abstract][Full Text] [Related]
20. Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage.
Bomhard E; Maruhn D; Vogel O; Mager H
Arch Toxicol; 1990; 64(4):269-78. PubMed ID: 2386429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
